Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024 ; volume:33 ; number:8 ; day:9 ; month:7 ; year:2024 ; pages:2029-2046 ; date:8.2024
Quality of life research ; 33, Heft 8 (9.7.2024), 2029-2046, 8.2024
- Creator
-
Elsman, Ellen B. M.
Mokkink, Lidwine B.
Terwee, Caroline B.
Beaton, Dorcas
Gagnier, Joel J.
Tricco, Andrea C.
Baba, Ami
Butcher, Nancy J.
Smith, Maureen
Hofstetter, Catherine
Aiyegbusi, Olalekan Lee
Berardi, Anna
Farmer, Julie
Haywood, Kirstie L.
Krause, Karolin R.
Markham, Sarah
Mayo-Wilson, Evan
Mehdipour, Ava
Ricketts, Juanna
Szatmari, Peter
Touma, Zahi
Moher, David
Offringa, Martin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11136-024-03634-y
- URN
-
urn:nbn:de:101:1-2410132108078.498122736917
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Elsman, Ellen B. M.
- Mokkink, Lidwine B.
- Terwee, Caroline B.
- Beaton, Dorcas
- Gagnier, Joel J.
- Tricco, Andrea C.
- Baba, Ami
- Butcher, Nancy J.
- Smith, Maureen
- Hofstetter, Catherine
- Aiyegbusi, Olalekan Lee
- Berardi, Anna
- Farmer, Julie
- Haywood, Kirstie L.
- Krause, Karolin R.
- Markham, Sarah
- Mayo-Wilson, Evan
- Mehdipour, Ava
- Ricketts, Juanna
- Szatmari, Peter
- Touma, Zahi
- Moher, David
- Offringa, Martin
- SpringerLink (Online service)
Other Objects (12)
How can we improve the interpretation of systematic reviews?
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024
Correction: Characteristics of ‘mega’ peer-reviewers
Characteristics of ‘mega’ peer-reviewers
Guidelines for randomized clinical trial protocol content: a systematic review
Reporting guidelines: doing better for readers
Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis
Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis
Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review
Reporting guidelines for realist evaluations seek to improve clarity and transparency
Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: Protocol for a systematic review and network meta-analysis
How can we improve the interpretation of systematic reviews?
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024
Correction: Characteristics of ‘mega’ peer-reviewers
Characteristics of ‘mega’ peer-reviewers
Guidelines for randomized clinical trial protocol content: a systematic review
Reporting guidelines: doing better for readers
Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis
Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis
Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review
Reporting guidelines for realist evaluations seek to improve clarity and transparency
Safety, effectiveness, and cost of long-acting versus intermediate-acting insulin for type 1 diabetes: Protocol for a systematic review and network meta-analysis
How can we improve the interpretation of systematic reviews?
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024
Correction: Characteristics of ‘mega’ peer-reviewers
Characteristics of ‘mega’ peer-reviewers
Guidelines for randomized clinical trial protocol content: a systematic review
Reporting guidelines: doing better for readers
Interventions to decrease the risk of adverse cardiac events for post-surgery or chemotherapy patients taking serotonin (5-HT3) receptor antagonists: protocol for a systematic review and network meta-analysis
Safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery and chemotherapy: protocol for a systematic review and network meta-analysis
Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review
Reporting guidelines for realist evaluations seek to improve clarity and transparency